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Abstract
Background: The Cryptococcus neoformans/C. gattii species complex comprises two sibling species that are divided into
eight major molecular types, C. neoformans VNI to VNIV and C. gattii VGI to VGIV. These genotypes differ in host range,
epidemiology, virulence, antifungal susceptibility and geographic distribution. The currently used phenotypic and molecular
identification methods for the species/molecular types are time consuming and expensive. As Matrix-Assisted Laser
Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) offers an effective alternative for the rapid
identification of microorganisms, the objective of this study was to examine its potential for the identification of
C. neoformans and C. gattii strains at the intra- and inter-species level.
Methodology: Protein extracts obtained via the formic acid extraction method of 164 C. neoformans/C. gattii isolates,
including four inter-species hybrids, were studied.
Results: The obtained mass spectra correctly identified 100% of all studied isolates, grouped each isolate according to the
currently recognized species, C. neoformans and C. gattii, and detected potential hybrids. In addition, all isolates were clearly
separated according to their major molecular type, generating greater spectral differences among the C. neoformans
molecular types than the C. gattii molecular types, most likely reflecting a closer phylogenetic relationship between the
latter. The number of colonies used and the incubation length did not affect the results. No spectra were obtained from
intact yeast cells. An extended validated spectral library containing spectra of all eight major molecular types was
established.
Conclusions: MALDI-TOF MS is a rapid identification tool for the correct recognition of the two currently recognized human
pathogenic Cryptococcus species and offers a simple method for the separation of the eight major molecular types and the
detection of hybrid strains within this species complex in the clinical laboratory. The obtained mass spectra provide further
evidence that the major molecular types warrant variety or even species status.
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Introduction
Cryptococcosis is a life-threatening infection caused for the
inhalation of infectious propagules of the encapsulated yeasts
Cryptococcus neoformans or C. gattii [1]. Cryptococcosis caused by C.
neoformans var. grubii (serotype A), C. neoformans var. neoformans
(serotype D) and the well-recognized hybrid AD is mainly an
opportunistic infection of HIV patients [2–4], while C. gattii
(serotypes B and C) is mainly affecting immunocompetent hosts,
involving humans, domestic and wild animals [2,5,6]. Both species
can be differentiated from each other by phenotypic methods [7],
and at intra-specific level, by a range of genotyping methods,
including PCR fingerprinting [8,9], restriction fragment length
polymorphism (RFLP) analysis [10], amplified fragment length
polymorphism (AFLP) analysis [11], multilocus microsatellite
typing (MLMT) [12] and multilocus sequence typing (MLST)
[13,14]. All currently used typing methods have identified eight
major molecular patterns (VNI/AFLP1, VNII/AFLP1A for C.
neoformans var. grubii, VNIII/AFLP3 for the AD hybrid, VNIV/
AFLP2 for C. neoformans var. neoformans and VGI/AFLP4, VGII/
AFLP6, VGIII/AFLP5 and VGIV/AFLP7 for C. gattii).
Strains of the eight major molecular types of the C. neoformans/
C. gattii species complex differ also in their mating type
distribution, virulence factors, disease characteristics, geographical
distribution, epidemiology and ecological niche [1,2,15]. Conse-
quently, the early and reliable diagnosis and the inter- and intra-
specific identification of the agents causing cryptococcosis are of
great importance for the clinicians, in order to allow for a prompt
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emerging highly virulent genotypes, considering that there are
differences in antifungal susceptibility patterns depending on the
molecular type of the strain [6,16–19]. However, correct
identification of cryptococcal species and the molecular types by
conventional methods can be sometimes difficult, expensive, and
time consuming, as well as laborious preparation of media and
reagents or extensive molecular investigations can be required
[20,21].
Recently as a substitute for phenotypic and genotypic method-
ologies used in clinical and applied laboratories, new, convenient
and highly standardized technologies for the diagnosis and
identification of infectious microorganisms to the subspecies level
have been described. Among them, matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF-
MS) is being well renowned as an important tool for the rapid
recognition of both bacteria [22,23] and fungal agents, including
the separation of the two pathogenic species C. neoformans and C.
gattii [24–31]. This technique determines within a few minutes,
specific patterns of peptides and protein mass spectra of either
intact microbial cells or cellular extracts from pure cultures or
from biological samples, allowing for the discrimination between
species by comparison of the obtained spectrum with those
included in a reference spectral library. Specific software packages
can be used to perform the data acquisition, analysis, identification
and result output [32,33].
Therefore, the aim of this study was to evaluate the use and
suitability of MALDI-TOF MS for a fast and reliable identification
of strains of the two currently recognized pathogenic yeasts C.
neoformans and C. gattii to the species/sub-species (major molecular
types) level. This is the first time that this technology is used to
identify and generate a library of the protein masses of clinical,
environmental and veterinary isolates of the C. neoformans/C. gattii
species complex representing all eight major molecular types
previously determined by molecular methods.
Results
Strain Identification to the Currently Accepted Species
Level
The analysis of 20 isolates for each of the eight major molecular
types of the C. neoformans/C. gattii species complex by MALDI-
TOF MS, resulted in a library of 960 individual mass spectra and
160 combined mass spectra, which allowed for the correct
identification of all isolates according to the two currently
recognized species C. neoformans and C. gattii, with identification
scores ranging between 1.882 and 2.711 (Table 1). A 100% correct
identification to the species level was obtained when the mass
spectra generated were compared to the reference spectra of the
five strains of C. neoformans and the two strains of C. gattii that are
currently included in the MALDI Biotyper BDAL MSP library
(2011) (see Materials and Methods). In general, the mass spectra
obtained from C. neoformans were characterized by diverse signals
in the region between 2050 and 9200 Da with strong peaks at
approximately, 3340 and 6680 Da, while C. gattii spectra varied
between 3030 and 9950 Da with strong peaks at approximately
3250, 4000 and 6650 Da. The peaks obtained at 7050, 7600 and
7900 Da, were found in both species. No isolate of the same
species or molecular type produced identical spectra.
Identification of the Major Molecular Types within the
C. neoformans/C. gattii Species Complex
In addition to the species identification, MALDI-TOF MS
grouped the obtained mass spectra according to the eight major
molecular types within the C. neoformans/C. gattii species complex.
Representative spectra obtained from the reference strains for the
seven haploid major molecular types are presented along with a
phylogram generated from randomly selected strains of those
major molecular types based on the concatenated sequences of the
ISHAM MLST consensus loci (CAP59, GPD1, LAC1, PLB1, SOD1,
URA5, and IGS1) [13] (Figure 1). The dendrograms obtained from
the mass spectra shown in Figure 2A and 2B group the isolates
according to the major molecular types VNI to VNIV for C.
neoformans and VGI to VGIV for C. gattii, respectively. The isolates
belonging to each molecular type produced distinct mass spectral
signatures that were distinguishable from each other (Figure 1 and
3). The specific protein mass and the intensity of the obtained
peaks characterizing each group of isolates within the same
molecular type are clearly visible using the gel view option of the
MALDI Biotyper software 3.0 (Bruker Daltonik GmbH) (Figure 3).
Detection of Hybrids
MALFI-TOF MS resulted in a 100% correct identification of all
studied AD hybrid strains (Figure 2 and 3). When analyzing four
inter-species hybrid strains, previously identified by URA5 RFLP,
no clear correlation with any of the eight major molecular types
was obtained. All hybrid strains were identified as belonging to the
C. neoformans/C. gattii species complex with identification scores
ranging between 1.728 and 2.304. The dendrogram generated
with the mass spectra of the isolates, located the hybrids separately
from the main clusters of the eight major molecular types.
However, all the hybrid isolates grouped very close to at least one
of the potential parental molecular types as previously determine
by URA5 RFLP analysis and Luminex suspension array [34] (data
not shown).
Reproducibility of the Obtained Spectra
Highly reproducible mass spectra were found when the proteins
were extracted at two different occasions after the same time of
incubation from the same isolate (data not shown). In addition,
when analyzing the spectra of the proteins extracted from one or
three colonies and incubated at 24 or 48 hours, no remarkable
changes in the obtained spectra were found. The spectra obtained
from one or three colonies or after 24 or 48 hours incubation
presented peaks in the same mass range and intensity. No spectra
Table 1. Scores obtained for the identification of
Cryptococcus neoformans and C. gattii isolates, using the
original un-supplemented MALDI Biotyper BDAL MSP library
(Bruker).
Species Molecular type Scores*
Cryptococcus neoformans VNI 2.055–2.445
VNII 2.319–2.358
VNIII 2.135–2.161
VNIV 2.083–2.204
Cryptococcus gattii VGI 2.012–2.711
VGII 2.055–2.166
VGIII 2.055–2.500
VGIV 1.882–1.945
*2.300–3.000: highly probable species identification; 2.000–2.299: secure genus
identification, probable species identification; 1.700–1.999: probable genus
identification.
doi:10.1371/journal.pone.0037566.t001
Cryptococcal Molecular Type ID by MALDI-TOF
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TOF plate.
Discussion
The distinction and characterization of pathogenic C. neoformans
and C. gattii isolates at the species or subspecies level is important,
mainly because of the differences in epidemiology, virulence, and
antifungal drug susceptibility and subsequent disease outcome of
the different strains [2,6,15,16–19]. In this study, MALDI-TOF
MS performed after a crude protein extraction generated highly
informative mass spectra, which allowed for the accurate and
reliable identification of 160 clinical, veterinary and environmental
isolates of the two main pathogenic yeast species C. neoformans and
C. gattii, as well as the detection of four newly recognized hybrid
strains [34], in a shorter time (25 hours including culturing or less
than one hour for crude protein extraction and MALDI-TOF
analysis only), using less reagents and fewer experimental
procedures, compared with conventional identification methods
[8–14,20,21]. This is a fundamental improvement over the
currently used molecular methods for the identification of the
major molecular types within the C. neoformans/C. gattii species
complex. URA5 RFLP, which is currently the most commonly
used method to determine the major molecular types, e.g. includes
not only culturing the isolates, but also to carry out DNA
extraction, URA5 gene amplification and restriction enzyme
digestion, followed by additional electrophoresis steps for the two
latest procedures, with the whole process taking at least 3 days
[10].
The herein obtained results are broadening the findings from
recent studies, which reported that mass spectrometry-based
identification proved to be a fast, reliable and sensitive alternative
for the correct identification of a broad range of human
pathogenic filamentous fungi and yeast [24–26,30], including C.
neoformans and C. gattii, although in previous studies, the isolates of
both pathogenic Cryptococcus species were only identified to the
species level [27–29,31].
Additionally to the species differentiation among clinical
Cryptococcus isolates, the MALDI-TOF technique also allowed for
a clearly separation of the major molecular types of the C.
neoformans/C. gattii species complex (Figure 1). These findings are in
agreement with a previous study using MLST of the unlinked
nuclear genes ACT1, IDE, PLB1 and URA5 [14], and with our
MLST analysis (CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and
IGS1), in which separate or combined sequence analyses of all four
or seven loci, respectively, revealed well-defined groups with
significant support for each major molecular type, suggesting that
the major molecular types are cryptic species and as such deserve
either variety or species status [14], a fact that is reemphasized by
the herein presented MALDI-TOF data. In our study, the spectra
obtained from strains within each major molecular type were more
homogeneous within C. neoformans than within C. gattii.I n
C. neoformans, the two varieties, C. neoformans var. grubii and
C. neoformans var. neoformans, were clearly separated, which is in
accordance with the grouping of the serotypes A and D,
respectively [2,15]. In C. gattii, despite the fact that four different
genotypes have been well identified by several molecular methods,
they have not yet been interpreted as distinct taxa [14], as both
WM 148
WM 626
WM 179
WM 178
WM 175
WM 779
WM 629
VNI
VNII
VNIV
VGI
VGIII
VGII
VGIV
Cng
Cg
Cnn
Figure 1. MLST phylogram of Cryptococcus neoformans and C. gattii isolates obtained using the ISHAM MLST consensus scheme for
the C. neoformans/C. gattii species complex (CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and IGS1), and associated mass spectra from the
respective reference strains for each major molecular type (for strain info see Material and Methods); Cnn = C. neoformans var.
neoformans, Cng = C. neoformans var. grubii and Cg = C. gattii; bootstrap values given above the lines.
doi:10.1371/journal.pone.0037566.g001
Cryptococcal Molecular Type ID by MALDI-TOF
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37566Cryptococcal Molecular Type ID by MALDI-TOF
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37566serotypes, B and C, occur in all genotypic groups [2,15]. The
obtained results most likely reflect a closer evolutionary relation-
ship between the major molecular types of C. gattii (Figure 2A and
2B). C. neoformans var. grubii (VNI/VNII) separated from C.
neoformans var. neoformans (VNIV) 24, VNI and VNII 4.7 and the C.
gattii major molecular types VGIII and VGI 8.5, VGIV 11.7 and
VGII 12.5 million years ago [14,35].
MALDI-TOF MS proved once again its potential to be very
useful for species differentiation, as has been already reported for
the discrimination of e.g. Mycobacterium isolates, at both the species
and strain level [22], for the identification of germ tube-negative
Candida species [26] and for the identification of members of the
Pseudallescheria/Scedosporium species complex [25]. For the first time,
20 mass spectra, composed of 6 single spectra for each major
molecular type were added to the spectral library. The ability to
correctly identify strains to the subspecies/major molecular types
within the C. neoformans/C. gattii species complex was greatly
enhanced through the addition of 160 new spectra to the MALDI
Biotyper BDAL MSP library (2011), containing currently only five
C. neoformans and two C. gattii spectra. From now on, it will be
possible to use the mass spectra obtained for the recognition of the
two currently recognized pathogenic Cryptococcus species, C.
neoformans and C. gattii, and the differentiation of the major
molecular types. This method can be used as a single identification
technique or to complement traditional morphological or molec-
ular identification/typing techniques like PCR fingerprinting,
RFLP, AFLP, and MLST [7,8–14].
As well as the identification of the currently recognized species
and the major molecular types within the C. neoformans/C. gattii
species complex, MALDI-TOF MS permitted the detection of
recently characterized inter-species hybrid strains [34]. Until now
intra- and inter-species hybrids have only been described on the
basis of molecular analysis [2,36–39]. The current study investi-
gated one VNI/VGI and three VNI/VGII inter-species hybrids
[34]. They were all correctly identified as belonging to the C.
neoformans/C. gattii species complex but did not group within any of
the eight major molecular types. In all cases they grouped closely
to one of the parental major molecular type, VNI. It is currently
unclear why they did not group in between both of the parental
major molecular types. This could reflect different contribution of
each parent strain to the gene composite of the hybrids or different
expression levels of the proteins involved. A clear grouping of the
well-known AD hybrid, VNIII/AFLP3 was obtained. Further
studies with more proven hybrid strains for each molecular type
combination are needed to assess the usability of the MALDI-
TOF MS for the identification of hybrids and the parental origins.
Considering that different strains within the C. neoformans/C.
gattii species complex are also characterized by different single
nucleotide polymorphisms (SNPs) [13,14] and that mass spec-
trometry based genotyping has recently been used for strain typing
within several microorganisms, due to its advantages of speed and
its ability to search for virulence factors and antibiotic resistance
determinants [40], further studies are warranted to investigate the
use of MALDI-TOF MS for cryptococcal strain typing.
In opposite to reports for other fungal species such as Candida
albicans, for which it was reported that it is important to consider
parameters that could affect mass signature reproducibility, like
the number of cells used, the cell incubation conditions, the matrix
compound used, or even the sample spotting technique [29], the
number of colonies used in this study and the length of incubation
of the strains or the spotting of the extract on the MALDI-TOF
plate did not affect the obtained results. However, although
protein purification steps were not required, it was always
necessary to perform a protein extraction before placing the
samples on the MALDI-TOF plate. Direct analyses of intact cells
did not result in mass spectra, unlike for mass spectra analysis for
bacterial identification [32] and for some other fungi, e.g. species
of the genus Candida [33]. When analyzing Cryptococcus isolates, it is
necessary to use ethanol in the protein extraction method, not only
to avoid cellular aggregations, but also to inactivate this pathogen.
Figure 2. MSP dendrograms grouping A) mass spectra of Cryptococcus neoformans and B) C. gattii strains according to their major
molecular type.
doi:10.1371/journal.pone.0037566.g002
Figure 3. Gel view of the MSP of the obtained mass spectra of Cryptococcus neoformans and C. gattii strains according to their major
molecular type.
doi:10.1371/journal.pone.0037566.g003
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critical to obtain high-quality mass spectra from yeast cells, and to
be essential in the success of the technique for the identification of
fungal species with the same accurate results as for bacterial
species, for which no prior treatment or extraction method is
needed [23,29,33]. The MALDI-TOF MS permitted as well to
check for the reproducibility of the technique without using more
reagents and almost at the same time, by spotting each sample
extract six times on the MALDI-TOF target plate.
In conclusion, MALDI-TOF MS is an effective tool for the
inter- and intra-specific differentiation of strains of the human
pathogens C. neoformans and C. gattii. The comprehensive in-house
library of the obtained mass spectra created in this study is
substantially improving the MALDI Biotyper BDAL MSP library
(2011), provided by Bruker, allowing for its use for the
identification of the currently recognized two pathogenic Crypto-
coccus species. MALDI-TOF MS analysis provides for the first time
a clear, rapid and highly reproducible method for the separation/
identification of the major molecular types within the C. neofor-
mans/C. gattii species complex and the detection of hybrids in the
clinical diagnostic laboratory setting. Although the use of MALDI-
TOF MS has until now been relatively limited for fungal
identification compared with its application for bacterial identifi-
cation, it is a cost-effective, rapid, sensitive and easy-to-handle tool
for the early identification of these clinically important human
pathogens. The diversity among the mass spectra obtained from
isolates of the major molecular types, which is comparable with
those obtained from other well defined yeast species, provides
further evidence that the seven major haploid molecular types are
cryptic species, which deserve separate species status.
Materials and Methods
Isolates
The usability of MALDI-TOF MS for the classification of the
major molecular types within the C. neoformans/C. gattii species
complex was investigated using 116 clinical, 32 environmental and
16 veterinary C. neoformans and C. gattii isolates (Table S1)
[6,8,10,11,14,34,41–51]. All studied isolates were maintained at
the culture collection of the Molecular Mycology Research
Laboratory, University of Sydney at Westmead Hospital, West-
mead, Australia. The references strains for C. neoformans, WM 148
(VNI, serotype A), WM 626(VNII, serotype A), WM 628 (VNIII,
AD hybrid) and WM 629 (VNIV, serotype D) and for C. gattii,
WM 179 (VGI, serotype B), WM 178 (VGII, serotype B), WM 175
(VGIII, serotype B) and WM 779 (VGIV, serotype C) were studied
initially to generate reference spectra for each major molecular
type. Subsequently, 20 isolates per molecular type were chosen
randomly from over 3000 global cryptococcal strains to evaluate
the ability of MALDI-TOF to distinguish between the eight major
C. neoformans/C. gattii molecular types.
After analyzing all the spectra obtained from the 140 isolates
with haploid genotypes (VNI, VNII, VNIV, VGI-VGIV) and 20
AD hybrids (VNIII), 4 additional inter-species hybrids strains were
analyzed to assess the ability of the MALDI-TOF to detect
potential hybrids. The strains tested included one VNI/VGI and
three VNI/VGII hybrids previously identified by URA5 RFLP
analysis and Luminex suspension array [34] (Table S1).
Major Molecular Types Determination
The major molecular type of all isolates was identified by RFLP
analysis of the orotidine monophosphate pyrophosphorylase gene
(URA5) via double digestion with the enzymes Sau96I and HhaI as
previously reported [10].
Multilocus Sequence Typing (MLST)
Nine strains of each of the seven haploid major molecular types
of C. neoformans and C. gattii were studied by MLST using the
ISHAM consensus MLST typing scheme for the C. neoformans/C.
gattii species complex, which includes the following seven genetic
loci: CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and IGS1 [13].
The strains for the haploid C. neoformans major molecular type VNI
were: WM 05.406, WM 05.473, WM 05.475, WM 05.479, WM
05.496, WM 05.553, WM 05.557, WM 09.170, WM 148, for
VNII were: WM 05.483, WM 05.484, WM 05.485, WM 05.486,
WM 05.490, WM 05.491, WM 05.523, WM 1816, WM 626 and
for VNIV were: WM 01.126, WM 01.127, WM 02.142, WM
04.171, WM 04.172, WM 04.174, WM 05.469, WM 2242, WM
629. The strains for the haploid C. gattii major molecular type VGI
were: WM 01.34, WM 02.103, WM 02.204, WM 05.410, WM
05.449, WM 08.108, WM 1009, WM 11.115, WM 179, for VGII
were: WM 03.312, WM 03.697, WM 04.75, WM 04.78, WM
04.84, WM 05.272, WM 05.274, WM 05.275, WM 05.339, for
VGIII were: WM 02.138, WM 02.139, WM 06.38, WM 09.43,
WM 09.44, WM 09.45, WM 09.47, WM 11.10, WM 11.106 and
for VGIV were: WM 04.20, WM 1220, WM 2363, WM 2579,
WM 779, WM 780, WM 08.314, WM 1434, WM 2570.
A phylogram of the studied strains was obtained with PAUP*
4.0b10 (Figure 1). The obtained MLST data are incorporated into
our in house C. neoformans/C. gattii databases accessible at
mlst.mycologylab.org.
MALDI-TOF MS
Isolates were cultured on Sabouraud dextrose agar and
incubated for 48 h at 27uC. For the protein extraction one colony
of each isolate was transferred separately into a 1.5 ml tube
(Eppendorf) containing 300 mL of double-distilled water and
mixed thoroughly for 1 minute. Subsequently, 900 mL of absolute
ethanol was added in each tube and mixed for 1 minute. The
samples were centrifuged for 2 minutes at 13000 rpm and the
supernatant was removed. The pellet was dried at room
temperature and according to the size of the pellet, 30 mL (small
pellet) or 50 mL (big pellet) of formic acid (70%) was added. In
addition, an equivalent volume of acetonitrile was added and the
mix was centrifuge for 2 minutes at 13000 rpm. After cleaning the
MALDI target plate, 1 mL of the supernatant was place in each
well, dried at room temperature (5 minutes), and overlaid with
1 mL of the matrix containing a saturated solution of a-cyano-4-
hydroxy-cinnamic acid in 50% acetonitrile/2.5% trifluoroacetic
acid. The plate was let to dry at room temperature before placing
in the MALDI-TOF reader. Each obtained extract was placed in 6
different spots on the plate to generate 6 combined mass spectra
(MSP) per isolate. Mass spectra were generated using the MALDI
Biotyper Automation Control software version 2.0.43.8 (BRU-
KER, Germany).
The proteins of the reference strains were extracted twice per
isolate to assess the reproducibility of the results. To evaluate the
effect of the number of colonies and the growth conditions of the
isolates in the mass spectra obtained, one and three colonies of the
reference strains incubated for 24 and 48 hours, were studied.
Intact cells of the references strains were also placed directly in the
MALDI-TOF plate in order to evaluate the extraction method.
Data Analysis
The MALDI Biotyper software 3.0 (Bruker Daltonik GmbH)
was used to identify the isolates, to visualize the mass spectra and
to generate the MSP dendrograms. The scores for identification
were expressed as log(score) values, indicating highly probable
species identification (2.300–3.000), secure genus identification
Cryptococcal Molecular Type ID by MALDI-TOF
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genus identification (1.700–1.999). The dendrograms were gener-
ated with the following settings: seuclidean as distance measure,
ward linkage and 1 (one) as the maximum number of top levels
nodes. One strain of each C. flavus (DSM70227T), C. laurentii
(VML), C. macerans (DSM70822T), C. albidus (DSM 70197 PAH)
and C. uniguttulatus (DSM 4652, DSM 70225), two of C. gattii
(formerly classified as C. bacillisporus (RV490)) and five of C.
neoformans (29 PSB, ATCC 14116 THL, CCM 8312, RV07 0218
and wVML) were used as reference spectra for the identification of
the isolates, considering that they are the references for Cryptococcus
species included in the All spectra generated were added to the in-
house supplementary MALDI Biotyper BDAL MSP library
(2011).
Supporting Information
Table S1 Cryptococcus neoformans and C. gattii iso-
lates studied by matrix-assisted laser desorption/ioni-
zation time-of-flight mass spectrometry (MALDI-TOF-
MS).
(DOC)
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